NCT05099861

Brief Summary

The study is focused on clinical anatomy of superficial veins of lower limbs. We are mapping their anatomy via ultrasonography. We are focusing on saphenopopliteal junction and communicants between small saphenous vein and great saphenous vein.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 29, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

February 13, 2023

Status Verified

February 1, 2023

Enrollment Period

12 months

First QC Date

October 18, 2021

Last Update Submit

February 9, 2023

Conditions

Saphenous Vein Injury

Keywords

small saphenous veingreat saphenous veinsaphenopopliteal junctionvenae intersaphenae

Outcome Measures

Primary Outcomes (1)

  • The Anatomy of superficial Veins of Lower Limbs

    the anatomy observed by ultrasonography imaging focus on communicans between small saphenous vein and great saphenous vein

    2022-2024

Secondary Outcomes (1)

  • The Anatomy of Superficial Veins of Lower Limbs: junction saphenopopliteal

    2022-2024

Study Arms (2)

healthy volunteers

Healthy volunteers with no sign of internal disease. Age 18-50, both women and men.

Other: No intervention

patients with internal disease

Patients with internal disease, both women and men.

Other: No intervention

Interventions

No interventionOTHER

this is an observational study

healthy volunteerspatients with internal disease

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

European population

You may qualify if:

  • women and men
  • age 18-80

You may not qualify if:

  • wounds on lower limbs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First faculty of medicine, Charles University

Prague, 12200, Czechia

Location

Study Officials

  • Michaela Hronová, doctor

    1. faculty of Medicine, Charles University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MUDr.

Study Record Dates

First Submitted

October 18, 2021

First Posted

October 29, 2021

Study Start

November 1, 2021

Primary Completion

October 30, 2022

Study Completion

August 1, 2023

Last Updated

February 13, 2023

Record last verified: 2023-02

Locations

CZ(1)